Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GSLO holding up nicely. News should be out soon hopefully...
I agree that you should be careful with this and all stocks. It's certainly not Apple at .30 cents a share. As far as the Peel 520 Not being available. Here's a link I found for it in about 3 seconds. The reviews are not stellar but hey it works! Not surprised really, an Ipod touch is an Iphone with the phone part stripped out. I guess the peel puts the phone part back in it.
http://www.amazon.com/Peel-Adapter-Compatible-iPod-Touch/product-reviews/B004C4GBQW/ref=dp_top_cm_cr_acr_txt?ie=UTF8&showViewpoints=1
Now as for the $59.95 Peel 520 goes as a product. Shure it's "cool" to be able to make a phone out of an Ipod and I'm not knocking it. I'm sure there are a lot of kids that want one. But I own three or four Ipods, an Ipad, Iphone, Imac, Macbook. each one for me has it's place in my life. I don't really use the ipods much anymore. My iphone has done away with a need for one. Actually the Iphone does so many things for me in the course of a day accept one, battery life... enter the Volt... That's the killer product to me. The Peel is for sale on Amazon. So I'm sure the Volt will be out there once it's available too.
Now there are other Chargers out there but I have a 3gs and may get an Iphone 4. The Volt Solar Charger works on all of them and looks better, has a better charging system, To quote Charlie Sheen... WINNING!
Oh yeah I forgot to mention when I bought my most recent shares of GSLO I did it using an APP on my Iphone while away from the office... People use their Iphones for everything that is until the Battery runs out.
Go, Go Solar = GSLO ... More News coming!
Here's a link from Google finance
http://www.zacks.com/research/get_news.php?id=095l7518
Inching up this morning, someone's buying.
I just went to Amazon and typed in peel 520. It's there for sale and $69.99... So there it is. I don't have an ipod touch and am really interested in the iphone solar charger. My Iphone 3gs doesn't last a Half day especially if I'm checking stocks all day on 3G. a solar charger would help a lot and that's what I want. so, I can't be alone. build it and they will come is what I say. I hope i get picked for a free one. If Not sign me up, I'll buy it!
I bought today...
****NEWS****
10 days till the completion of manufacturing Volt Charger!
GO GSLO
http://www.businesswire.com/news/home/20110330005330/en/GSLO-Volt-Manufacturing-Nearing-Completion
SNRS is a diluted 16.6 Billion crappy .0002 per share Market cap stock. GSLO 35.6 Million vs. Billion and .30 cents plus stock. I urge everyone to break out a calculator and do the math. How much of the company do you actually own when you buy a $1,000 of stock. you need a scientific calculator to pull off the snrs calculations because it's so valueless it's a Carl Sagan Stock. Billions and Billions of shares. I assure you Grants_aor we are not all dumb. I'll hold the GSLO shares I bought and if they start selling chargers will celebrate with my 35.6 million partners.
Buddy Rich
Great Day, I haven't been playing pennies for a while but heard about this stock reading some Apple news. I have been wanting a solar device to charge my Iphone and looked into a few different options but this seems to be the most prayer answering device yet... As an investor in AAPL, an Iphone user, and now an investor in GSLO... I can't wait to buy one of these new cases. I can't be alone that's why I bought stock and feel way ahead of the curve on this one. Anyone have any insight into this company?
New news! Volt shipping in next 30 days!
We have a video clip posted from CNBC by svatos. maybe that's worthy of the sticky section at the top?
Nice Job Posting that clip. Sounds good to me. I'm going to be adding some more when I can. Not a lot of traffic here, nice to be in on the ground level.
I saw the CNBC report yesterday. They did say the tests would be done early 2011. And said it is a target of a bidding war. That's the first I have heard of the company. I bought shares yesterday. Good luck
Hey Folks, I'm new here. Bought a million shares today. My thinking is this. just selling the show alone could be very profitable. With a blockbuster show sold they would ride that wave with new show ideas of which they probably have many. Who knows how many other shows they are working on. Developing shows and selling them is still good business. Tremendous upside either way. Good luck everyone!
Hi Folks, Long time no speak, sorry, had nothing to say. The video is totally over exposed and the wire for the microphone is in plain sight. A sign of a complete amateur video production company shooting this thing. Even more likely, one of there kids with imovie, Sheesh! come on ERHC get it together out there. We need positive news and a professional company pulling it all together. This video is crap!
I'm counting on a huge rush leading up to and after todays CC... It's a mess down there and this company has the right stuff to clean it up. Here's the good.... cleaned up Pink image, was asked by BP to come down and demonstrate product, released good news about product tests, promptly scheduled Conference call, Call is at 2pm today. has been holding .04... get ready for take off... I'm in last week at .049 and doubled down today .039...
doubled down at 39
Anything under .05 is a steal... IMO
An easy double.
I'm in Looks good, Great news, just bought a little 10,000 shares but will double up a few times if it drops at all... This could be a great ride from that news...
There Will Be Blood
Any one have any thoughts on drainage seepage?
Anyone think it's a good time to buy?
Total is pulling oil out right next door...
Thank You!
Exactly
YUP!
Sinopec would release bad results (if there were any). since it would most likely drive the price of the EEZ lower if anything. Unless they were not interested in the EEZ at all, then they would post them and move on...
I've gone back and looked at Mark's previous posts. His sources have been accurate before. Timing is never fast enough for anyone. Everyone is in a rush to get news, see share price soar. ERHC has great stuff going on right now. Drilling has happened. I remember waiting for that for years and years. Anyone who's new to this has no idea what many of us have been through. The company has survived many struggles and is in the best position yet... The share price should be higher but it's not and until they have a big news release or income they will continue to struggle. they live on the money they got from sharing their blocks. They have more blocks to share now, 100% in 2. 15% in another 2. And my bet is the latter will be bid on by there existing partners.
Mark seems to be a very nice fellow from his posts and I send best wishes to his family...
I agree that if you are going to post this type of message you "need" to at least follow through and say something, anything. Sorry folks! My source is busy buying groceries, for a friend, whose in from out of town and can't talk, he/she was hit by a bus, stubbed a toe, hates me because I call asking questions all the time, Source was waxed/fired for leaking info, or most probably, source has stopped giving me info for now... I feel like the guy in that movie waiting in the restaurant for that girl who never shows up... Oh yeah I remember. Dumb and Dumber, WE LANDED ON THE MOON!
The best post I've seen here of late was full of facts... Thank You!
I don't know anything, just like everyone else but, since so many are hungry for rumors and speculation Here's my "guess".... The delays are because there's a lot down there. If the results were not good they would release the news and move on! That's just common sense. But, if there's a bucket load, they may be motivated to keep it quiet, why? There is a chance to acquire some more yummy blocks in the area at a lower price. Can you all jump for joy and say EEZ, ERHC will get a lot of money from just sharing those 2 100% blocks! and still have to pick another 2 15% Blocks... WOW!!! and that's without even opening there wallets!
GO ERHC!!!
Fantastic Post! Thank You
NOVAVAX Releases Final Results from its Trivalent Seasonal Influenza Vaccine Phase II Clinical Study in Healthy Adults
Last update: 3/29/2010 8:00:00 AM
ROCKVILLE, Md., March 29, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (NVAX) a clinical-stage vaccine company, released the final results from a Phase II clinical trial evaluating Novavax's trivalent seasonal influenza Virus-like particle (VLP) vaccine candidate in healthy adults. The study enrolled healthy volunteers 18 to 49 years in age who were immunized with a single injection of Novavax's trivalent seasonal influenza VLP vaccine matched to the influenza strains recommended for the 2008-2009 influenza vaccine. Preliminary data from this trial were reported in 2009.
The complete analysis included 232 volunteers in total; with 49 receiving placebo, 83 given Novavax's trivalent seasonal influenza VLP vaccine at 15 mcg/dose, 81 injected with Novavax's trivalent seasonal influenza VLP vaccine at 60 mcg/dose and 19 volunteers receiving an inactivated trivalent influenza vaccine Fluzone(R) (TIV) at 15 mcg/dose. The three strains were H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006. The data show that Novavax's trivalent seasonal influenza VLP vaccine induced a robust hemagglutination inhibition (HAI) antibody response against all three strains in the vaccine. Seroconversion rates as defined by the FDA (including lower and upper 95% Confidence Intervals (CI)) for the 15 mcg group were as follows: 51% (39, 62), 76% (65, 85), and 58% (47, 69) against the H1N1, H3N2, and B strains, respectively. Seroprotection (titer greater than or equal to 1:40) rates for volunteers in the 15 mcg group (with 95% CIs) were 70% (59, 80), 89% (80, 94), and 84% (75, 91) against the H1N1, H3N2, and B strains, respectively.
Preliminary HAI results from this study were presented at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) on October 31, 2009 and were described in a company press release dated November 2, 2009. Those interim results were based on evaluation of a total of 190 volunteers, of which 37 received placebo, 69 received trivalent seasonal influenza VLP vaccine at 15 mcg/dose, 67 received trivalent seasonal influenza VLP vaccine at 60 mcg/dose and 17 received TIV. For volunteers in the 15 mcg group, seroconversion rates (greater than or equal to 4-fold rise in titer from baseline) with the accompanying 95% CI were 57% (44, 68), 86% (75, 93), and 62% (50, 74) against the H1N1, H3N2, and B strains, respectively. For volunteers in the 15 mcg group, seroprotection rates (titer greater than or equal to 1:40) with 95% CI were 67% (54, 78), 91% (82, 97), and 84% (73, 92) against the H1N1, H3N2, and B strains, respectively. In the final results reported today, the H3N2 and B strain data in the 15 mcg VLP dose met the FDA seroconversion guidelines of 40 (lower 95% CI) while the H1N1 data fell just short (39.4 versus 40.0). However, the mean seroprotection rate against the H1N1 strain rose slightly from an original 67% to a final 70%.
In addition to the HAI titers, functional antibody against the Neuraminidase enzyme was measured in the sera of immunized subjects using a neuraminidase inhibition assay (NAI). Inhibition of neuraminidase activity may be important in reducing the spread and severity of influenza infection. Novavax tested volunteers for NAI against B/Florida, H3N2/Brisbane and H1N1/Brisbane components of the vaccine before and after immunization. Against the B strain, 59% of the patients receiving the 15 mcg dose of VLP showed a 4-fold or higher rise in NAI titers over pre-immune levels. At the 60 mcg VLP dose, 73% had a 4-fold rise while only one subject (5%) from the TIV population had a 4-fold rise. In the NAI assay against the H3N2 strain, 50% of the patients immunized with the 15 mcg VLP dose had a 4-fold rise in NAI titers. At the 60 mcg VLP dose, 56% had a 4-fold rise. In the small subset of subjects tested against H1N1 NAI activity (10 placebo and 20 at the 60 mcg VLP dose), the NAI in the VLP treated group increased about 30% over preimmunization levels while the placebo treated group had no increase over pre-immunization levels.
"The data released today show that our VLP influenza vaccine not only induces a robust HAI response but also enhances the NAI response far above that induced by TIV," said Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax. "We will continue measurement of NAI activity in other clinical trials since we believe that the ability of the VLP vaccine to elicit an NAI response may differentiate our vaccine from others. These NAI results support our position that VLP influenza vaccines have the potential to induce a broad-based immune response that could lead to improved clinical outcomes. We now await comparative immunological and safety data from a larger head to head clinical trial in older adults (>60 years of age) between TIV and our VLP vaccine," said Dr. Singhvi.
About VLPs
Virus-like particles (VLPs) mimic the external structure of viruses but lack the live genetic material that causes viral replication and infection. VLPs can be designed quickly to match individual viral strains and be produced efficiently using portable cell-culture technology. Novavax VLP-based vaccine candidates are produced more rapidly than egg-based vaccines by using proprietary, portable, recombinant cell-culture technology.
About Novavax
Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based, recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. It launched in 2009 a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: .
Forward-Looking Statements
Statements herein relating to future performance, conditions or strategies and other matters, including expectations regarding clinical trials, release of new data, continued development of the seasonal vaccine and its potential differentiation, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include historical and current results may not be predictive of future trial results for the seasonal vaccine or any other vaccine that we are developing or may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if the results are similar or better than the results reported to date; uncertainties related to the initiation, enrollment, progress and completion of clinical trials; safety or efficacy issues not seen to date may be encountered; the market or industry experts may not accept that our neuraminidase results show a differentiation of our vaccine from other vaccines; the immune systems of the elderly pose significant challenges for vaccines and our products may not be as efficacious in the elderly as they have been in test subjects to date; the Company has not yet manufactured, or relied on third parties to manufacture, any vaccines at a commercial scale; and the seasonal flu vaccine industry is intensely competitive, making it difficult for our vaccine to have market success even if approved. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at . These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.
SOURCE Novavax, Inc.
Copyright (C) 2010 PR Newswire. All rights reserved
HERE WE GO!
Would someone help me with this report? Decrease in revenue? No payments from Merck does that mean Merck's no longer involved? or does it mean that Merck came on board gave us money so we show higher revenue last year. This year that's not there so that's why the decrease in revenue. Thanks BR
SINOPEC/ERHC will release the news when they are ready. Are you ready?
Virus, What's that? You must be using one of those other computers. Get a MAC
Who knows how long it usually takes to get listed on the AIM?
Hi Ponzi, I understand your point and you are absolutely right. drilling here and there will give different results there's hits and there's misses... But you must admit you have a better chance of swinging a bat and getting a hit, while standing at home plate rather than off in left field. IMO the JDZ is home plate and AKPO is just one strike in the area...
I know you've all seen this already but here's the map of AKPO-1 and the JDZ
http://www.equatorialoil.com/images/AnnobonRegionalMap.gif
This is a great video. Thanks for posting... AKPO is very close to the JDZ and although I know there are some that say it's people "piecing together" the puzzle. This is a huge oil field that is successful and currently producing and it is right next to us... IMO we have tons of oil down there. When it happens you'll know and so will everyone else in the world...
Ever see someone light a firecracker and step back and wait for it to go off and it doesn't, it smolders, on lookers start to walk away, the brave guy goes over tries to kick it, re-light it, and then, just as they get real close it explodes in there face... that's what this feels like to me... It just feels like something is about to EXPLODE! I hope it's today...